Premium
Hong Kong-based alternative investment firm PAG Asia Capital has joined two Indian private equity firms to build a bulk-drugs platform that is now chasing a second deal, two people with knowledge of the matter told VCCircle. PAG has teamed up with CX Partners and Samara Capital for the platform, which has ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
